Athenex Announces $225 Million Loan Agreement with Oaktree

NEXT STORY
Ascendis Pharma A/S Announces Presentation of Preclinical Data for TransCon IL-2 β/γ at AACR Virtual Annual Meeting 2020
PREV STORY
In Vitro Diagnostics (IVD) Market Worth $87.21 Billion by 2024, Growing at a CAGR of 5.7% – Global Opportunity Analysis and Industry Forecasts by Meticulous Research®
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

argenx announces first patient dosed in Phase II proof-of-concept study of ARGX-113 for the treatment of primary immune thrombocytopenia

-Topline data from the study expected in second half of 2018- 31 March 2017 ...

author_avatar
NASDAQ Market News

Tiziana Life Sciences Announces Initiation of Clinical Trial in a Secondary Progressive Multiple Sclerosis (SPMS) Patient with Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, Under an Individual Patient Expanded Access Program

author_avatar
NASDAQ Market News

SDU Researchers Develop ECMO Proto Device in Aid of Fighting COVID-19

author_avatar
NASDAQ Market News